Showing results (511-520 of 566) with videos related to

Sort By:
Pageof 57
Journal of Clinical Medicine|September 17, 2020
Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic MelanomaFiona A Lynch, Lynda Katona, Michael Jefford, et al.
Journal of Medicinal Chemistry|April 9, 2015
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep)William H Parsons, Raul R Calvo, Wing Cheung, et al.
Rheumatology (Oxford, England)|April 19, 2022
Development and validation of the Kids Disability Screen for children with juvenile idiopathic arthritis: results from the CAPRI RegistryKristin Houghton, Meghan McPherson, Nikola Surjanovic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2024
Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label StudiesDahlene Fusco, Ivana Malenica, Huldrych F Günthard, et al.
Journal of Medicinal Chemistry|March 18, 2005
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonistDevin M Swanson, Adrienne E Dubin, Chandra Shah, et al.
Academic Radiology|March 7, 2020
Toward Developing a Semiquantitative Whole Body-MRI Scoring for Juvenile Idiopathic Arthritis: Critical Appraisal of the State of the Art, Challenges, and OpportunitiesJyoti Panwar, Hiten Patel, Mirkamal Tolend, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor ProgressionStephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield, et al.
Plos Pathogens|May 5, 2026
An orthoflavivirus inhibitor targeting multifunctional NS2A protein, a previously unidentified targetDoortje Borrenberghs, Kitti Wing Ki Chan, Sven Van Brandt, et al.
United European Gastroenterology Journal|December 7, 2021
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosisMathias Jachs, Teresa Binter, Caroline Schmidbauer, et al.
Human Molecular Genetics|December 22, 2017
FRMPD4 mutations cause X-linked intellectual disability and disrupt dendritic spine morphogenesisJuliette Piard, Jia-Hua Hu, Philippe M Campeau, et al.
Pageof 57